Allspring Global Investments
DNA icon

Allspring Global Investments’s Ginkgo Bioworks DNA Stock Holding History

Allspring Global Investments’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-531
Closed -$4.33K – 1946
2024
Q3 		$4.33K Buy
531
+328
+162% +$3.29K ﹤0.01% 2201
2024
Q2 		$2.71K Buy
+203
New +$6.06K ﹤0.01% 2266
2022
Q3 		– Sell
-14
Closed -$1K – 2883
2022
Q2 		$1K Buy
+14
New +$1.71K ﹤0.01% 2661

Other funds holding DNA

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Allspring Global Investments's DNA Position: Q4 2024 in Review

Allspring Global Investments sold out of Ginkgo Bioworks (DNA) in Q4 2024, closing a stake of 531 shares — an estimated $4.33K sold.

Allspring Global Investments first reported a position in DNA in Q2 2022 and held it in 3 quarters. The position peaked at $4.33K in Q3 2024. 166 funds tracked by Wall St. Rank hold DNA as of Q4 2024.

  • Allspring Global Investments reported no remaining Ginkgo Bioworks position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 531 Ginkgo Bioworks shares in Q4 2024, an estimated $4.33K.
  • Allspring Global Investments first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 3 quarters.
  • Allspring Global Investments's Ginkgo Bioworks position peaked at $4.33K in Q3 2024.
  • 166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.